Implementing Geriatric Assessment for Dose Optimization of Cyclin-dependent Kinase (CDK) 4/6-inhibitors in Older Breast Cancer Patients

NCT06044623 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

495

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Breast Cancer
Advanced Breast Cancer
Quality of Life
Toxicity
Older Patients

Interventions

DRUG: CDK 4/6 inhibitors
DRUG: Endocrine therapy

Sponsor

Region Örebro County

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]